About the Exhibitors

Acorda Therapeutics

Acorda Therapeutics, Inc. is an American biotechnology company based in New York. The company develops therapies that improve neurological function in people with Parkinson’s disease, multiple sclerosis and other neurological disorders.

Aesculap

Founded over 150 years ago, Aesculap is the world’s leading manufacturer of surgical instrumentation and sterilization containers.   Coupling old-world craftsmanship with cutting edge innovation, the company remains on the vanguard of medical technology, producing advanced products for disciplines such as neuro, spine and joint replacement surgeries with a strong emphasis in the areas of hydrocephalus management, high speed and micro power systems, and robotic microscopy. 

Alexion Pharmaceuticals

Alexion, AstraZeneca Rare Disease, was created in 2021 following AstraZeneca’s acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

Amylyx Pharmaceuticals

Amylyx Pharmaceuticals began in 2013 with a simple question “Why do neurons die?”  Our mission is centered on a commitment to people living with neurodegenerative diseases, their families and to the healthcare providers who support them. This start-up is headquartered in Cambridge, MA with offices in Canada and Europe.

AstraZeneca Pharmaceuticals

AstraZeneca is a global science-led biopharmaceutical company.

Azurity Pharmaceuticals

Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company. The portfolio of products marketed in the U.S. by Azurity includes GLIADEL® Wafer (carmustine implant) and Nymalize® (nimodipine) Oral Solution, the first and only FDA-approved nimodipine oral solution. Gliadel® is manufactured by Eisai Inc. for Arbor Pharmaceuticals, LLC, a subsidiary of Azurity Pharmaceuticals, Inc. and Gliadel® is a registered trademark of Eisai Inc.

BK Medical

BK Medical provides reassurance for decision-making in neurosurgery. Whether you specialize in neuro-oncology, skull base, spine, neurovascular, functional, or pediatrics, use real-time intraoperative ultrasound to achieve planned results.

BrainLab

Brainlab creates software-driven med tech digitizing, automating and optimizing clinical workflows. Serving physicians, medical professionals and patients in 6000+ hospitals in 121 countries, we’re transforming healthcare to improve the lives of patients everywhere. We employ over 2000 people in 25 locations worldwide. Visit and follow: Brainlab, LinkedIn , Twitter , Facebook  and Instagram .

Ceribell

Ceribell is a medical device company with a primary mission of improving neurological care for emergency and ICU patients. We’ve developed the world’s first point-of-care noninvasive brain function monitor for critical and emergency care. This device integrates machine learning AI and cloud-based computing with miniaturized EEG technology so it is easy to apply and use. Now, with Ceribell, rapid EEG technology can be brought to frontline emergency and critical care doctors so you have rapid clinical answers at the bedside.

CSL Behring

CSL Behring is a global bio therapeutics leader driven by its promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease, and neurological disorders.

DePuy Synthes Spine

DePuy Synthes, the Orthopedics Company of Johnson & Johnson, provides one of the most comprehensive Orthopedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. DePuy Synthes Spine offers an expansive portfolio of spinal care solutions and treatment options which are available in key areas including thoracolumbar, cervical, aging spine, interbody fusion, and arthroplasty.  Building on our proud product innovation and legacy of industry firsts, we are reimagining the orthopedic landscape with new advancements in medical technologies and digital surgery across the entire continuum of care to Keep People Moving today and tomorrow. 

Elekta

Elekta is a Swedish company that provides radiation therapy, radiosurgery, related equipment and clinical management for the treatment of cancer and brain disorders

Hyperfine

Hyperfine is the groundbreaking medical device company that created Swoop®, the world’s first US FDA-cleared portable MRI system—created to provide neuroimages at the patient’s bedside and enable rapid diagnosis and treatment regardless of income, resources, or location. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making insights across various clinical settings.

Jazz Pharmaceuticals

At Jazz Pharmaceuticals plc, our purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases – often with limited or no options – so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again.

LivaNova

As pioneers of the VNS Therapy System ™, we continue to advance medical device solutions for people affected by treatment-resistant epilepsy. We strive to help where it really counts, where it truly matters the most. Sharp, responsive and effective—at LivaNova we serve health and improve lives. Day by day. Life by life.

Lundbeck Pharmaceuticals

Lundbeck, a global biopharmaceutical company based in Denmark and founded in 1915, is tirelessly dedicated to restoring brain health, so that every person can be their best. Lundbeck has a long heritage of innovation in neuroscience and is focused on delivering transformative treatments that address unmet needs in brain health. For more information, visit us at www.lundbeck.com/us.

Marinus Pharmaceuticals

Marinus is a commercial stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders. The Company’s lead product candidate, ganaxolone oral suspension CV, is approved by the FDA for the treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder in patients two years of age and older. The potential of ganaxolone is being studied in other rare seizure disorders, including in Phase 3 trials in tuberous sclerosis complex and refractory status epilepticus. Ganaxolone is a neuroactive steroid GABAA receptor modulator that acts on a well-characterized target in the brain known to have anti-seizure effects. It is being developed in IV and oral formulations to maximize therapeutic reach for adult and pediatric patients in acute and chronic care settings. For more information visit www.marinuspharma.com.

MedSol

MedSol has maintained its mission of providing clinically superior products that demonstrate proven advantages in quality, efficiency, safety and overall cost.

Medtronic Brain and Spine

Our mission is to contribute to human welfare by application of biomedical engineering and medical devices in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life.

Miami Neuroscience Institute

Miami Neuroscience Institute offers comprehensive and compassionate treatment for neurological conditions affecting the brain, spinal cord and peripheral nervous system. From non-surgical treatments and minimally invasive procedures to complex brain and spine surgery, the Institute embraces a multidisciplinary approach to patient care.

Microvention

MicroVention provides a complete 360-degree approach to developing neuroendovascular technologies with four main product groups: Aneurysm Therapy Solutions, Ischemic Stroke and Carotid Artery Disease Solutions, Neurovascular Malformation Solutions, and Access Products. Additionally, our extensive product lines in each category allow our customers to uniquely address the needs of their patients.

Neurelis

Neurelis, Inc. is an innovation-driven neuroscience company providing a highly differentiated approach to target unmet medical needs.  Neurelis is focused on the development and commercialization of product candidates for epilepsy and the broader central nervous system (CNS) market.  We are built on a foundation of people with a passion for progress in serving the needs of people with epilepsy and those who care for them.

Neurocrine Biosciences

Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and commercializing life-changing treatments for people with serious, challenging and under-addressed disorders. The company's diverse portfolio includes four FDA-approved treatments as well as clinical programs in multiple therapeutic areas. Headquartered in San Diego, Neurocrine Biosciences specializes in targeting and interrupting disease-causing mechanisms. For more information, visit neurocrine.com, and follow the company on LinkedIn.

NicoNeuro

NICO is a leader in interventional technologies for neurosurgery. Using a parafascicular trans-sulcal surgical approach, a combination of standardized patented technologies achieves non-disruptive access to the brain with NICO BrainPath, automated tumor removal and clot evacuation with NICO Myriad NOVUS, and intraoperative tissue collection and preservation with the NICO Automated Preservation System. A proven market leader with over 10 years of evidence and 30,000 patient lives impacted.

Octapharma

Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein products manufacturers in the world and has been committed to patient care and medical innovation since 1983. Its core business is the development and production of human proteins from human plasma and human cell lines. Octapharma employs more than 10,000 people worldwide to support the treatment of patients in over 115 countries with products across the following therapeutic areas: Hematology (coagulation disorders), Immunotherapy (immune disorders) and Critical Care. The company’s American subsidiary, Octapharma USA, is located in Paramus, N.J. Octapharma operates three state-of-the-art production sites licensed by the U.S. Food and Drug Administration (FDA), providing a high level of production flexibility. For more information, please visit octapharmausa.com.

Omniscient Neurotechnology

Omniscient Neurotechnology (o8t™) builds personalized brain maps to diagnose, treat and prevent health conditions. A pioneer in connectomics, o8t™ is poised to change the future of neuroscience. Currently used by neurosurgeons to visualize the brain’s pathways prior to a procedure, the company’s technology ultimately aims to transform brain health and address conditions such as Alzheimer’s disease and depression.

Penumbra

“Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries.”

Rapid AI

RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Empowering physicians to make faster decisions for better patient outcomes. RapidAI is leading the next evolution of clinical decision-making and patient workflow. Based on intelligence gained from over 5 million scans in more than 2,000 hospitals in over 60 countries, the Rapid®️ platform transforms care coordination, offering care teams a level of patient visibility never before possible. RapidAI – where AI meets patient care.

Siemens Healthineers

By constantly bringing breakthrough innovations to market, Siemens Healthineers enables healthcare professionals to deliver high-quality care, leading to the best possible outcome for patients. At Siemens Healthineers, our mission is to enable healthcare providers to increase their value by equipping them with our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine as well as digital health and enterprise services. Our global portfolio, spanning from in-vitro and in-vivo diagnostics to image-guided therapy and innovative cancer care, is crucial for clinical decision-making and treatment pathways. With our strengths in patient twinning, precision therapy, as well as digital, data, and artificial intelligence (AI), we are well positioned to take on the biggest challenges in healthcare. We will continue to build on these strengths to help fight the world’s most threatening diseases, improving the quality of outcomes, and enabling access to care.

SMI Cold Therapy

SMI Cold Therapy is a Virginia based manufacturer of simple, but effective cold compression therapy wraps for post-op ortho/neuro, general surgery, and oncology used by over 600 programs nationwide. Proud to be 100% Made in America, SMI is clinically proven to provide the highest levels of pain/edema relief, while eliminating several patient and staff hassles.

Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.

Sunovion Pharmaceuticals

At Sunovion, we strive to serve and create value for patients every day. By developing innovative therapies that treat serious Central Nervous System (CNS) conditions, science leads the way—guiding us to a healthier tomorrow.

TEVA Neuroscience

In a complex world, Teva's mission is simple: to improve the lives of patients across the globe. We believe that everyone should have access to quality medicines whether it be for managing disease, fighting infections, or simply improving overall health.

UCB

UCB is focused on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions.

Viz.Ai

Viz.ai is the leader in AI-driven intelligent care coordination. Viz.ai’s mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce time to treatment, improve access to care, and increase the speed of diffusion of medical innovation.